OR WAIT null SECS
There is a great need for sensitive, precise, and easily accessible analytical detection techniques for protein sequencing.
The emergence of mRNA vaccines and cell and gene therapies has pushed innovation in analytical methods.
Effective analytics will eliminate failures, deviations, and non-conformances.
April 30, 2008
Also, Genzyme to build R&D center in Beijing, Noven Pharmaceuticals appoints Peter C. Brandt president and CEO, more...
Researchers from the Georgia Institute of Technology described a fast method to detect counterfeit "Tamiflu," Roche's drug for preventing and treating bird flu.
April 22, 2008
The United States Pharmacopeial Convention (USP) has agreed to work with the US Food and Drug Administration on developing more sensitive tests for detecting contaminants such as over-sulfated chondroitin, which was found in batches of heparin last January.
Also, GSK expands in Ireland, executive appointments at ProGenTech, more...
April 16, 2008
The US Food and Drug Administration issued a final guidance last week regarding investigational new drug applications for human gene therapy.
Also, Alcon plans to open Singapore facility, Pharmacopeia president and CEO retired, more...
April 10, 2008
Also, Jubilant Organosys to acquire DRAXIS Health, PPD's Paul Covington to retire, more...
Combining atomic force microscopy and infrared spectroscopy, scientists at the University of Illinois have demonstrated a method for simultaneous structural and chemical characterization of samples at the femtogram (10-15g) level.
The US Food and Drug Administration withdrew a direct final rule that changed current good manufacturing practice (CGMP) regulations for finished pharmaceuticals. The agency withdrew the rule because it received significant adverse comments from industry.
April 03, 2008
Also, VaxGen and Raven terminate merger agreement, Darren Head appointed CEO of Cytovance, more...